Related Experiment Video
Updated: Aug 30, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
1.7K
Percutaneous closure of left ventricular pseudoaneurysm
1The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, China.
Summary
Percutaneous closure effectively treats left ventricular pseudoaneurysm (LVPA), especially in high-risk patients. Avoiding iatrogenic trauma is key to preventing LVPA formation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Left ventricular pseudoaneurysm (LVPA) is a rare but serious cardiac condition.
- LVPA can arise from surgical complications, percutaneous interventions, or medial disease.
- Coronary artery bypass grafting is a frequent cause of iatrogenic LVPA.
Purpose of the Study:
- To review the indications for percutaneous LVPA management.
- To evaluate the treatment effects and patient outcomes of percutaneous LVPA closure.
- To provide guidance on device selection for percutaneous LVPA repair.
Main Methods:
- Comprehensive literature search from 2004 onwards.
- Analysis of patient data regarding LVPA formation mechanisms and timelines.
- Review of percutaneous closure success rates and complications.
Main Results:
- Percutaneous closure achieved a 84.9% success rate on the first attempt.
- LVPA formation time varied, with medical disease-related cases taking up to 44.4 months.
- Percutaneous closure is a viable option for patients with high surgical risk.
- Specific device selection criteria (oversize 3.3 mm, oversize ratio 1.6) were identified.
Conclusions:
- Percutaneous LVPA management offers a successful alternative to surgery for high-risk patients.
- Preventing iatrogenic causes, like left ventricular venting, is crucial.
- Adherence to device selection guidelines can improve procedural success.
